| Evaluation Recommendations | Management Response | Management Action Plan | Deliverables | Expected Completion Date | Responsibility | Accountability | |
|---|---|---|---|---|---|---|---|
| 1 | Prioritize and implement NIS performance measurement framework (PMF) | AGREE Priorities identified in the interim evaluation will be used to develop a monitoring system that builds upon the NIS Performance Management Framework. | 1) The performance measurement framework developed for the evaluation will be operationalized into a monitoring system to routinely assess the performance of selected indicators over time and establish baselines | 1) Performance monitoring plan | 1) Aug 08 | Evaluation Officer | Program Monitoring and Evaluation Unit (PM&E Unit) |
| 2) Reporting format and schedule will be established | 2) CIC approval | 2) Nov 08 | PM&E Unit | CIC | |||
| 3) Quantitative data will be incorporated into the performance measurement framework | 3) Performance monitoring plan & routine reports | 3) March 09 | Eval Officer | PM&E Unit | |||
| 1a | Incorporate measurable data in subsequent evaluations i.e. surveillance, coverage and cost data from P/Ts in the performance management system | AGREE WITH CONDITIONS A cost analysis is dependant on availability of data. P/Ts are not willing/able to disclose program costs and are inhibited from sharing info on the purchase price of vaccines due to contractual obligations | 1) Consult with the stakeholders to attempt to resolve issues inhibiting the collection of financial data and discuss options | 1) Recommendation from CIC to include cost related indicators or options. | 1) 2008/2009 | CIRID | CIC |
| 2) The summative evaluation will focus on the intermediate outcomes which are more quantifiable i.e. surveillance and coverage data | 2) See Evaluation Framework [This info is included in the PMF] Indicators for Success | 2) 2011 | CIRID | CIC | |||
| 1b | Use an external FPT group to provide insight and assessment of the NIS | AGREE | A task group of CIC will be assigned to oversee the subsequent summative evaluation | Task group ToR | 2011 | PM&E Unit | CIC |
| 2 | Enhance thecommunication between CIC and NACI | AGREE 1) The introduction of the new HPV vaccine was used as an opportunity to test the analytic framework and define a collaborative working relationship between NACI and CIC |
1a) Joint task group was formed to assess the best programmatic recommendations for the introduction of the new HPV vaccine | 1a) Coordinated statements published | 1a) NACI Feb 07 CIC June 2008 | Immunization Program Section | CIC & NACI Secretartiate |
| 1b) The collaboration between the two committees will be evaluated and lessons learned will be applied to improve collaboration in the future | 1b) Evaluation summary shared with both committees | 1b) April 2008 | Immunization Program Section | ||||
| 2) Review the governance of CIC and NACI | 2) The roles of CIC and NACI will be reviewed by CIRID as part of a Centre-wide restructuring | 2) Revised CIC and NACI ToRs | 2) 2008/2009 | CIRID | PHN | ||
| 3 | Increase the interaction between NIS working groups | AGREE Communication between working groups is a key area to be addressed in order to prevent duplication of work and to promote collaborative relationships | 1) CIRID will develop a communication strategy to encourage a flow of information between working groups | 1) Working groups will update each other on their activities annually through participation at annual meetingsand sharing of minutes of meetings and teleconferences | 2008/2009 and Ongoing | W/group co-chairs | CIRID & CIC |
| 2) CIC will facilitate working group collaboration and coordination. | 2) CIC will request working group co-chairs to report on their efforts to improve communication to CIC | ||||||
| 4 | Increase the roles for NGOs on working groups | DISAGREE NGOs are already key players in the implementation of the NIS. Currently, NGOs are members of various working groups and CIC invites NGOs to attend their meetings once a year. CIC and its w/groups have FPT representation, increased involvement of NGOs may impede communication between FPT reps. ] | CIC will continue to share summaries of meetings, PHAC news releases and media lines, and seek NGO input on NIS issues as appropriate. | Minutes, reports and media lines | 2008/2009 and Ongoing | CIC secretariate | CIC |
| 5 | Allocate specific resources directly to working groupswhere NIS budgets permit | AGREE Progress of priority activities would be improved in working groups if each had budgets with which they could commission studies, literature reviews, etc. | Working groups will be provided with funding based on work plan/ budget requests. | Budget lines will be included in FY2008-9 budget. | FY 2008 | W/ group co-chairs | CIRID |
| 6 | Continue to develop and focus on a long term vision | AGREE | 1) Work with stakeholders to set research and evaluation priorities | 1a) Disease specific research priorities w/shop for Flu & HPV 1b) Non voting member of the HPV Evaluation & Research Committee |
1) Completed Nov 2005/6 1b) Feb. 2008 |
Research Coord Research Coord |
IRID
IRID |
| 2) Investigate possible funding mechanisms to support a coordinated research/ evaluation program for new and existing vaccines | 2) Funding mechanism defined as part of the renewal of NIS | 2) 2011 | CIC/PHAC | PHN | |||
| 3) CIRID/PHAC will host an international forum on immunization funding models assess and recommend a best practice model for continued federal funding of immunization programs in Canada. | 3) The findings of the forum will be presented in a report that includes a summary of best practices of relevance to Canada (An initial review was prepared in June 07) |
3) 2008/2009 | CIRID-Policy Section | CIC | |||
| 4) A comprehensive international review of immunization funding models and consultations with international contacts and P/Ts will be conducted | 4a) A literature review of funding models 4b)Analysis report from contractor |
4a) 2009 4b) 2009 |
|||||
| 5) Contractor hired to perform an in-depth analysis of a selected funding models (possible RFP & contract) | 5) Potential funding options and a recommended funding model for immunization programs in Canada will be presented to CIC and PHN. | 5) 2010 |
To share this page just click on the social network icon of your choice.